Cumberland Pharmaceuticals Inc (CPIX)

Apr 18, 2025

Cumberland Pharmaceuticals' (NASDAQ:CPIX) growing losses don't faze investors as the stock swells 18% this past week - simplywall.st

Apr 18, 2025

Apr 10, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World

Apr 10, 2025

Apr 06, 2025

Cumberland Pharmaceuticals director Caroline Young acquires $383 in common stock - Investing.com Australia

Apr 06, 2025

Apr 05, 2025

Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock By Investing.com - Investing.com South Africa

Apr 05, 2025

Apr 05, 2025

Cumberland Pharmaceuticals director James Jones buys shares worth $880 By Investing.com - Investing.com South Africa

Apr 05, 2025

Apr 04, 2025

Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock - Investing.com

Apr 04, 2025

Apr 04, 2025

Cumberland Pharmaceuticals CEO A.J. Kazimi acquires $880 in common stock - Investing.com

Apr 04, 2025

Apr 04, 2025

Cumberland Pharmaceuticals director James Jones buys shares worth $880 - Investing.com India

Apr 04, 2025

Mar 25, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average – What’s Next? - Defense World

Mar 25, 2025

Mar 21, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 21, 2025

Mar 19, 2025

FIGHT DMD trial results selected for late-breaking presentation at MDA clinical & scientific conference - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Breakthrough DMD Heart Disease Treatment Achieves 5.4% Function Boost While Controls Decline - Stock Titan

Mar 19, 2025

Mar 19, 2025

FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference - PR Newswire

Mar 19, 2025

Mar 12, 2025

Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Here’s Why - Defense World

Mar 12, 2025

Mar 10, 2025

Earnings call transcript: Cumberland Q4 2024 results show revenue rise By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 09, 2025

CPIX Stock Price and Chart — NASDAQ:CPIX - TradingView

Mar 09, 2025

Mar 08, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World

Mar 08, 2025

Mar 07, 2025

Cumberland Pharmaceuticals Inc. (CPIX) reports earnings - Quartz

Mar 07, 2025

Mar 07, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call Transcript - MSN

Mar 07, 2025

Mar 07, 2025

Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 05, 2025

Cumberland Pharma stock soars to 52-week high of $7.25 By Investing.com - Investing.com Canada

Mar 05, 2025

Mar 05, 2025

Cumberland Pharmaceuticals: Key Insights from Earnings Call - TipRanks

Mar 05, 2025

Mar 05, 2025

Cumberland Pharma stock soars to 52-week high of $7.25 - Investing.com India

Mar 05, 2025

Mar 05, 2025

Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada

Mar 05, 2025

Mar 05, 2025

Cumberland: Q4 Earnings Snapshot - Midland Daily News

Mar 05, 2025

Mar 04, 2025

Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances - TipRanks

Mar 04, 2025

Mar 04, 2025

Earnings call transcript: Cumberland Q4 2024 results show revenue rise - Investing.com

Mar 04, 2025

Mar 04, 2025

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth - TradingView

Mar 04, 2025

Mar 04, 2025

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth -March 04, 2025 at 04:52 pm EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Cumberland: Q4 Earnings Snapshot -March 04, 2025 at 04:51 pm EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - BioSpace

Mar 04, 2025

Mar 03, 2025

Glenmark Pharmaceuticals Acquires & Launches Acetylcysteine Injection In The U.S. - bwhealthcareworld.com

Mar 03, 2025

Mar 02, 2025

Glenmark acquires Acetylcysteine injection, launches in US market - BusinessLine

Mar 02, 2025

Mar 01, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 117% - Simply Wall St

Mar 01, 2025

Feb 27, 2025

Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Cumberland Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 25, 2025

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS - PR Newswire

Feb 25, 2025

Feb 24, 2025

(CPIX) Trading Report - news.stocktradersdaily.com

Feb 24, 2025

Feb 21, 2025

Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet? - Simply Wall St

Feb 21, 2025

Feb 19, 2025

Cumberland Pharma stock soars to 52-week high of $6.43 By Investing.com - Investing.com South Africa

Feb 19, 2025

Feb 19, 2025

Cumberland Pharma stock soars to 52-week high of $6.43 - Investing.com

Feb 19, 2025

Feb 18, 2025

Cumberland Pharmaceuticals' Pneumonia Injection Receives Approval in China -February 18, 2025 at 08:19 am EST - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - Finansavisen

Feb 18, 2025

Feb 18, 2025

Corneal Ulcer Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, NDA Approval, Prevalence, Incidence, Therapies, and Companies by DelveInsight - The Globe and Mail

Feb 18, 2025